Literature DB >> 20537458

myc maintains embryonic stem cell pluripotency and self-renewal.

Natalia V Varlakhanova1, Rebecca F Cotterman, Wilhelmine N deVries, Judy Morgan, Leah Rae Donahue, Stephen Murray, Barbara B Knowles, Paul S Knoepfler.   

Abstract

While endogenous Myc (c-myc) and Mycn (N-myc) have been reported to be separately dispensable for murine embryonic stem cell (mESC) function, myc greatly enhances induced pluripotent stem (iPS) cell formation and overexpressed c-myc confers LIF-independence upon mESC. To address the role of myc genes in ESC and in pluripotency generally, we conditionally knocked out both c- and N-myc using myc doubly homozygously floxed mESC lines (cDKO). Both lines of myc cDKO mESC exhibited severely disrupted self-renewal, pluripotency, and survival along with enhanced differentiation. Chimeric embryos injected with DKO mESC most often completely failed to develop or in rare cases survived but with severe defects. The essential nature of myc for self-renewal and pluripotency is at least in part mediated through orchestrating pluripotency-related cell cycle and metabolic programs. This study demonstrates that endogenous myc genes are essential for mESC pluripotency and self-renewal as well as providing the first evidence that myc genes are required for early embryogenesis, suggesting potential mechanisms of myc contribution to iPS cell formation. Copyright 2010 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537458      PMCID: PMC2916696          DOI: 10.1016/j.diff.2010.05.001

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  60 in total

Review 1.  Self-renewal vs. differentiation of mouse embryonic stem cells.

Authors:  K Sue O'Shea
Journal:  Biol Reprod       Date:  2004-08-25       Impact factor: 4.285

2.  Myc-binding-site recognition in the human genome is determined by chromatin context.

Authors:  Ernesto Guccione; Francesca Martinato; Giacomo Finocchiaro; Lucilla Luzi; Laura Tizzoni; Valentina Dall' Olio; Giuseppe Zardo; Clara Nervi; Loris Bernard; Bruno Amati
Journal:  Nat Cell Biol       Date:  2006-06-11       Impact factor: 28.824

3.  Myc influences global chromatin structure.

Authors:  Paul S Knoepfler; Xiao-yong Zhang; Pei Feng Cheng; Philip R Gafken; Steven B McMahon; Robert N Eisenman
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

4.  Characterization of Dicer-deficient murine embryonic stem cells.

Authors:  Elizabeth P Murchison; Janet F Partridge; Oliver H Tam; Sihem Cheloufi; Gregory J Hannon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-12       Impact factor: 11.205

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

6.  Specific microRNAs modulate embryonic stem cell-derived neurogenesis.

Authors:  Anna M Krichevsky; Kai-C Sonntag; Ole Isacson; Kenneth S Kosik
Journal:  Stem Cells       Date:  2005-12-15       Impact factor: 6.277

7.  Real-time quantitative PCR as an alternative to Southern blot or fluorescence in situ hybridization for detection of gene copy number changes.

Authors:  Jasmien Hoebeeck; Frank Speleman; Jo Vandesompele
Journal:  Methods Mol Biol       Date:  2007

8.  Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.

Authors:  Siqin Wu; Cihan Cetinkaya; Maria J Munoz-Alonso; Natalie von der Lehr; Fuad Bahram; Vincent Beuger; Martin Eilers; Javier Leon; Lars-Gunnar Larsson
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

9.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

10.  Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.

Authors:  Xiaohua Su; Vidya Gopalakrishnan; Duncan Stearns; Kenneth Aldape; Fredrick F Lang; Gregory Fuller; Evan Snyder; Charles G Eberhart; Sadhan Majumder
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

View more
  84 in total

Review 1.  Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer Therapies.

Authors:  Kristofor A Olson; John C Schell; Jared Rutter
Journal:  Trends Biochem Sci       Date:  2016-02-10       Impact factor: 13.807

Review 2.  Molecular mechanisms controlling the cell cycle in embryonic stem cells.

Authors:  Essam M Abdelalim
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

3.  The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.

Authors:  Jiabo Di; Tjitske Duiveman-de Boer; Petra L M Zusterzeel; Carl G Figdor; Leon F A G Massuger; Ruurd Torensma
Journal:  Cell Oncol (Dordr)       Date:  2013-08-09       Impact factor: 6.730

Review 4.  Roles for MYC in the establishment and maintenance of pluripotency.

Authors:  James Chappell; Stephen Dalton
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

5.  Molecular fingerprint of female bovine embryos produced in vitro with high competence to establish and maintain pregnancy†.

Authors:  A M Zolini; J Block; M B Rabaglino; P Tríbulo; M Hoelker; G Rincon; J J Bromfield; P J Hansen
Journal:  Biol Reprod       Date:  2020-02-14       Impact factor: 4.285

Review 6.  Inducing iPSCs to escape the dish.

Authors:  Bonnie Barrilleaux; Paul S Knoepfler
Journal:  Cell Stem Cell       Date:  2011-08-05       Impact factor: 24.633

7.  Myc orchestrates a regulatory network required for the establishment and maintenance of pluripotency.

Authors:  Keriayn N Smith; Jae-Min Lim; Lance Wells; Stephen Dalton
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

Review 8.  The tumorigenicity of human embryonic and induced pluripotent stem cells.

Authors:  Uri Ben-David; Nissim Benvenisty
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

9.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

10.  c-myc and N-myc promote active stem cell metabolism and cycling as architects of the developing brain.

Authors:  Alice Wey; Paul S Knoepfler
Journal:  Oncotarget       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.